Aporphine esters and their use in therapy
US7332503B2 · kind B2 · utility
1Cited by
2References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2005 |
| Grant date | Feb 19, 2008 |
| Priority date | — |
| Expiry date | Feb 22, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.